Finch M B, Johnston G D
Br J Clin Pharmacol. 1985 Nov;20(5):447-51. doi: 10.1111/j.1365-2125.1985.tb05095.x.
The acute effects of increasing doses of diltiazem on peripheral blood flow were observed in six subjects. Each subject received, in random order, a single oral dose of placebo or diltiazem 60, 120 or 180 mg. Supine heart rate, blood pressure, skin temperature, digital systolic pressure, forearm and digital blood flow were recorded before and at 1, 2, 3, 4 and 6 h post-dosing. Plasma diltiazem concentrations were measured at each time interval and at 12 and 24 h after the 120 mg dose. At doses of 120 and 180 mg, diltiazem significantly increased digital blood flow at 1, 2, 3, 4 and 6 h post-dosing and forearm blood flow at 2 and 3 h following 180 mg and 3 h following 120 mg. No correlation was observed between plasma diltiazem concentration and changes in peripheral blood flow.
在6名受试者中观察了递增剂量地尔硫䓬对外周血流的急性影响。每名受试者按随机顺序接受单次口服安慰剂或60、120或180毫克地尔硫䓬。在给药前以及给药后1、2、3、4和6小时记录仰卧位心率、血压、皮肤温度、指收缩压、前臂和指血流。在每个时间间隔以及120毫克剂量给药后12和24小时测量血浆地尔硫䓬浓度。在120和180毫克剂量时,地尔硫䓬在给药后1、2、3、4和6小时显著增加指血流,在180毫克给药后2和3小时以及120毫克给药后3小时显著增加前臂血流。未观察到血浆地尔硫䓬浓度与外周血流变化之间的相关性。